查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023年至2028年痤疮治疗市场预测
市场调查报告书
商品编码
1410017

2023年至2028年痤疮治疗市场预测

Acne Treatment Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

痤疮治疗市场预计将从2021年的188,107,000美元成长到2028年的244,810,000美元，复合年增长率为3.84%。

当毛囊被皮脂和死皮细胞堵塞时，就会出现痤疮。结果就是粉刺、黑头和白斑。痤疮可以发生在任何年龄，但最常见于青少年。痤疮盛行率的增加以及青少年人口的增加是痤疮治疗市场的主要成长驱动因素。

全球痤疮盛行率不断上升

由于生活方式改变、遗传和不规律的日常生活等因素，痤疮盛行率不断增加，这是痤疮治疗市场的主要成长要素。根据 IHME 的数据，2019 年寻常性痤疮影响了约 496 万人，并导致伤残调整生命年 (DALY)，其中 352 万人发生在 15 岁至 49 岁的老年人中。此外，成人痤疮的增加表明需要治疗，从而推动痤疮治疗市场的发展。

青少年人口增加

阻塞和痤疮爆发的主要原因是年龄，青少年和年轻人更容易患痤疮。世界青少年人口的增加导致痤疮增多，这表明痤疮治疗市场在未来几年将扩大。根据联合国儿童基金会预测，2022年4月，全球青少年人口将达到13亿，几乎占全球总人口的16%。根据约翰霍普金斯的说法，女孩的这种情况通常比男孩发生得更早，通常在青春期开始时发生。在大多数情况下，痤疮会消失，但大约 12% 的女性和 3% 的男性可能在 40 多岁时仍然有痤疮。此外，痤疮也会导致人的情绪和心理问题。青少年数量的不断增加，加上痤疮对心理的严重影响，预计将推动痤疮治疗市场的规模扩大。

技术进步和相关计划

技术的进步正在帮助开发增强型痤疮治疗方法，从而推动痤疮治疗市场的发展。根据美容外科论坛教员的说法，基于能量的设备几乎总是加速癒合过程，这对于不想等待标准的 8 到 12 週结果的痤疮患者来说至关重要。此外，其他相关措施也进一步推动了痤疮治疗市场的发展。例如，不列颠哥伦比亚省的医疗保健系统于 2023 年 6 月推出了一个网站，并开始预约药剂师治疗痤疮等小病。

市场机会

痤疮问题的盛行率上升以及青少年人口的增加正在迅速推动痤疮治疗市场的成长。此外，痤疮问题也源自于不良的饮食习惯、不良的卫生习惯、不讲卫生的情况，这在成年人中也普遍存在。例如，疾病预防控制中心估计，2 岁至 19 岁之间，十分之五的成年人和十分之六的儿童定期饮用一种或多种含糖饮料。这些痤疮高发生率的因素进一步为进入痤疮治疗市场提供了巨大的机会。

市场抑制因素

除了所有的成长要素之外，痤疮治疗的一些副作用预计将限制痤疮治疗市场的成长。局部痤疮药物的常见副作用是暂时干燥和发炎。内服药物可能会产生更严重的副作用，例如抗生素引起的消化不良和头晕。此外，痤疮药物会增加服用避孕药的女性出现血栓和高血压的风险。口服异维A酸（一种用于治疗严重痤疮的药物）可能会出现严重的副作用，特别是如果您在服用异维A酸期间怀孕了。有报导称，怀孕期间使用异维A酸的母亲所生的婴儿会出现严重的先天缺陷。

预计北美在预测期内将经历高速成长

预计在预测期内，北美将占据痤疮治疗市场的重要份额。这一市场份额归因于痤疮治疗的高采用率以及大量患有痤疮的人。例如，根据 AADA 的数据，每年约有 5,000 万美国患有痤疮，使其成为美国最常见的皮肤病。 AADA 估计，大约 85% 12 至 24 岁之间的人至少患有轻度痤疮。此外，Obagi、Skinmedica 和 Colorescience 等主要市场参与者的产品推出和供应，为痤疮治疗市场的成长做出了重大贡献。

市场主要发展

2022年9月，理肤泉推出了专门针对成人痤疮的全新Effaclar水杨酸痤疮治疗精华液。三重酸复合配方，含有乙醇酸、​​脂羟酸和 1.5% 水杨酸，可清除痤疮疤痕并有助于预防未来的痘痘。 2022年7月，Glenmark首次在印度推出用于治疗中重度痤疮的外用米诺环素4%凝胶。该凝胶适合 9 岁及以上儿童，与其他外用抗菌製剂相比，具有最低的 MIC90。 2021年11月，Sun Pharma开发的新型痤疮治疗霜Winlevi在美国市场上市。 Winlevi 霜适合 12 岁及以上人群，也是过去 40 年来第一个获得 FDA核准的痤疮治疗药物，具有First-in-Class的作用机制。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 先决条件

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
  • 产业价值链分析

第五章痤疮治疗市场：副产品

  • 介绍
  • 类视色素A
  • 抗生素
  • 异维A酸
  • 其他的

第六章痤疮治疗市场：依给药途径

  • 介绍
  • 口服
  • 热带

第七章痤疮治疗市场：按分销管道

  • 介绍
  • 医院药房
  • 零售及网路药局

第八章痤疮治疗市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作

第十章 公司简介

  • PHYTOMER
  • Skin Medica
  • PCA
  • Obaji
  • Colorescience
  • Revision Skincare
  • Sente
  • Jan Marini Skin Research
  • Botanix Pharmaceuticals
简介目录
Product Code: KSI061615654

The acne treatment market is expected to grow at a CAGR of 3.84% from US$188.107 million in 2021 to US$244.81 million in 2028.

When hair follicles become clogged with oil and dead skin cells, acne is a skin disorder that develops. It results in pimples, blackheads, or whiteheads. Although it can afflict anyone at any age, acne is most prevalent in teenagers. The growing prevalence of acne along with the rising adolescent population are the primary growth drivers of the acne treatment market.

Growing Prevalence of Acne Globally

The growing prevalence of acne due to factors such as changing lifestyles, genetics, and untimely routine is a major growth factor in the acne treatment market. According to the IHME, around 4.96 million people had acne vulgaris causing Disability-adjusted life year (DALY) in 2019 out of which, 3.52 million occurred in people aged between 15-49 years old. Moreover, acne in adults is increasing indicating the need for treatment thereby propelling the acne treatment market. According to the American Academy of Dermatology Association (AADA), around 15% of women are affected with acne annually which further widens the acne treatment market size as women are expected to be more image-conscious.

Rising Adolescent Population

The major cause of clogging and acne development is age as teenagers and younger adults are more affected by the acne. The rising global adolescent population causing more acne is indicating the acne treatment market expansion in the coming years. According to UNICEF, there were 1.3 billion adolescents worldwide in April 2022 making up almost 16% of the total world population. According to Jon Hopkins, Girls are typically affected earlier than boys, and it usually starts around the beginning of puberty. In most cases, acne is outgrown, although about 12% of women and 3% of men may still have acne in their 40s. Moreover, acne may cause emotional and psychological problems in a person. The growing teenage population along with the severe emotional impact of acne is contemplated to bolster the acne treatment market size.

Technological Advancements and Related Programs

The advances in technology are helping in the development of enhanced acne treatments which is propelling the acne treatment market. According to Cosmetic Surgery Forum Faculty members, Energy-based devices nearly always expedite the healing process, which is crucial for acne sufferers who don't want to wait the standard eight to 12 weeks for results. Additionally, other related efforts are further boosting the acne treatment market. For instance, the British Columbia Health Care system launched a website in June 2023 to book appointments with pharmacists for the treatment of minor ailments including acne.

Opportunities in the Market

The growing prevalence of acne problems along with the rising adolescent population is rapidly aiding the acne treatment market growth thereby providing an opportunity for market players to enhance the customer experience. Moreover, the problem of acne also happens from bad diet, poor hygiene, and sanitation which are also prevailing in adults. For instance, 5 out of 10 adults and 6 out of 10 children between the ages of 2 and 19 regularly consume one or more sugary beverages as per the CDC estimates. These factors causing the higher prevalence of acne further provide a phenomenal opportunity to enter the acne treatment market.

Restraints in the Market

Apart from all the growth factors, a few side effects of acne treatments are expected to limit the acne treatment market growth. The common side effects of topical acne drugs are dryness and irritation which are temporary. The more serious side effects can occur in the case of oral medications such as indigestion, or dizziness caused by antibiotics. Moreover, acne treatment medications can increase the risk of blood clots and high blood pressure in women taking birth control pills. Serious side effects from oral isotretinoin (a drug for severe acne) are possible, particularly if you become pregnant while taking it. According to reports, babies born to mothers who used isotretinoin during pregnancy had serious birth defects.

North America is Expected To Grow at a High Rate During The Forecast Period

North America is expected to hold a significant share of the acne treatment market during the forecast period. The factors attributed to such a share are a huge number of acne-affected people along with higher adoption of acne treatments. For instance, nearly 50 million Americans are affected with acne annually and it is the most common prevailing skin condition in the US as per the AADA. The estimates of the AADA suggest that around 85% of people get affected with at least minor acne and are aged between 12-24 years. Moreover, the presence of major market players such as Obagi, Skinmedica, and Colorescience further contributes significantly to the acne treatment market growth through product launches and easy accessibility.

Acne Treatment Market Players

  • Sente, founded in 2007 is helping physicians to address uneven skin concerns through several clinical tests. Medical experts have long employed therapeutically developed heparan sulfate analog (HSA) by the company to support the body's inflammatory healing process.
  • Obagi, a US-based transformative skincare company is serving the population for the last 35 years providing solutions for all skin types and tones. The company provides acne solutions through its Clenziderm Therapeutic lotion, Obagi 360 Retinol 1.0, Obagi Clinical Retinol 0.5 Retexturizing Cream, and Obagi 360 Retinol 0.5.
  • Revision Skincare offers disruptive skincare innovation with a mission to deliver benefits through products that patients can see. The company provides solutions to numerous skin concerns including loss of firmness, aging eyes, wrinkles, hyperpigmentation, fatigued skin, and acne.

Key Market Developments

  • In September 2022, a new Effaclar Salicyclic Acid Acne Treatment Serum was launched by La Roche Posay to specifically target adult acne. Effaclar Serum's Triple Acid Complex formula, which combines glycolic acid, lipo-hydroxy acid, and 1.5% salicylic acid, clears acne scars while assisting in the prevention of future outbreaks.
  • In July 2022, the first topical Minocycline 4% gel for the treatment of moderate to severe acne was introduced by Glenmark in India. This gel is suitable for people aged 9 years or above and compared to other topical antibacterial formulations available, it offers the lowest MIC90.
  • In November 2021, a new acne treatment cream Winlevi developed by Sun Pharma was launched in the US market. The Winlevi cream is suitable for people aged 12 years and above and it was also the first FDA-approved acne drug with a first-in-class mechanism in the last 40 years.

Segmentation:

By Product

  • Retinoids
  • Antibiotics
  • Isotretinoin
  • Others

By Route of Administration

  • Oral
  • Tropical

By Distribution Channel

  • Hospital Pharmacies
  • Retail & Online Pharmacies

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. ACNE TREATMENT MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Retinoids
  • 5.3. Antibiotics
  • 5.4. Isotretinoin
  • 5.5. Others

6. ACNE TREATMENT MARKET BY ROUTE OF ADMINISTRATION

  • 6.1. Introduction
  • 6.2. Oral
  • 6.3. Tropical

7. ACNE TREATMENT MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Retail & Online Pharmacies

8. ACNE TREATMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. PHYTOMER
  • 10.2. Skin Medica
  • 10.3. PCA
  • 10.4. Obaji
  • 10.5. Colorescience
  • 10.6. Revision Skincare
  • 10.7. Sente
  • 10.8. Jan Marini Skin Research
  • 10.9. Botanix Pharmaceuticals